Methotrexate for Cutaneous Sarcoidosis: A Dermatology-Based Case Series of 23 Patients

Abstract

Keywords

cutaneous sarcoidosis granulomatous methotrexate sarcoidosis treatment

Get full access to this article

View all access options for this article.

References

Haimovic

Sanchez

Judson

MA.

Prystowsky

. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699.e1-18 doi:10.1016/j.jaad.2011.11.965

22507585

Sharma

Bryer

JS.

Price

Noe

MH.

Rosenbach

. A prospective comparison of cutaneous sarcoidosis disease response to immunomodulatory and immunosuppressive therapies. J Am Acad Dermatol. 2020;82(6):1546-1548.doi:10.1016/j.jaad.2020.02.070

32151628

Lower

EE.

Baughman

. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155(8):846-851.doi:10.1001/archinte.1995.00430080088011

7717793

Veien

NK.

Brodthagen

. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol. 1977;97(2):213-216.doi:10.1111/j.1365-2133.1977.tb15068.x

911683

Webster

GF.

Razsi

LK.

Sanchez

Shupack

. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991;24(3):451-454.doi:10.1016/0190-9622(91)70071-9

2061444

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB